Skip to main content Accessibility help
×
Home

Dietary restriction of energy and sugar results in a reduction in human cytochrome P450 2E1 activity

  • Isabelle Leclercq (a1), Yves Horsmans (a1), Jean-Pierre Desager (a1), Stanislas Pauwels (a1) and André P. Geubel (a1)...

Abstract

Dietary habits are often considered as a pathogenic factor for fatty liver. The impact of dietary intake and steatosis on drug metabolism remains poorly investigated. Our aim was to assess the effect of dietary intake on in vivo cytochrome P450 (CYP) activities in eleven patients with abnormal liver function tests potentially due to fatty liver and associated with a high-sugar diet. Liver function tests, liver volume, aminopyrine breath test (ABT) and chlorzoxazone (CZ) pharmacokinetics (area under the curve, AUC) which are known to reflect CYP2E1 activity were evaluated before and after 2 months restriction of dietary sugar intake. Features at inclusion were an increased BMI (30·3 (sd 3·2) kg/m2), high hepatic volume (1·96 (sd 0·48) litres), hyperechogenic liver parenchyma, elevated liver enzyme activities (alanine aminotransferase (EC 2.6.1.2) 58·6 (sd 17·4) IU/l with alanine aminotransferase : aspartate aminotransferase (EC 2.6.1.1) ratio > 1), together with a normal ABT value (0·68 (sd 0·21) % specific activity of administered dose of [14C]aminopyrine in breath after 1 h) and a high CYP2E1 activity (CZ AUC 20·3 (sd 7·1) μg/ml per h). A dietary sugar restriction was prescribed. On the basis of repeated interviews by the same dietitian, unaware of any clinical and biochemical data, six patients remained compliant to the diet and exhibited reductions in BMI (P < 0·001), serum alanine aminotransferase (P = 0·008), liver volume (P = 0·002) and CYP2E1 activity (P = 0·007), a significant increase in ABT (P < 0·001) together with the disappearance of liver hyperechogenicity at ultrasound. In contrast, the five non-compliant patients did not show any significant change in any of these variables. In conclusion, CYP2E1 activity is induced in patients with perturbations of liver function tests potentially due to fatty liver. In these patients, effective dietary sugar restriction is associated with a reduction in liver volume, a reduction in CYP2E1 activity and an increased aminopyrine metabolism rate.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Dietary restriction of energy and sugar results in a reduction in human cytochrome P450 2E1 activity
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Dietary restriction of energy and sugar results in a reduction in human cytochrome P450 2E1 activity
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Dietary restriction of energy and sugar results in a reduction in human cytochrome P450 2E1 activity
      Available formats
      ×

Copyright

Corresponding author

*Corresponding author: Dr Y. Horsmans, fax +32 2764 8272, email Horsmans@gaen.ucl.ac.be

References

Hide All
Aarsland, A, Chinkes, D & Wolf, RR (1997) Hepatic and whole-body fat synthesis in humans during carbohydrate overfeeding. American Journal of Clinical Nutrition 65, 17741782.
Abdel-Razzak, Z, Loyer, P, Fautrel, A, Gautier, JC, Corcos, L, Turlin, B & Guillouzo, A (1993) Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary cultures. Molecular Pharmacology 44, 707715.
Acheson, KJ, Schutz, Y, Bessard, T, Ravussin, E, Jequier, E & Flatt, JP (1984) Nutritional influences on lipogenesis and thermogenesis after a carbohydrate meal. American Journal of Physiology 246, E62E70.
Adam, R, Reynes, M, Johann, M, Morino, M, Astarcioglu, I, Kafetzis, I, Castaing, D & Bismuth, H (1991) The outcome of steatotic grafts in liver transplantation. Transplantation Proceedings 23, 15381540.
Alpers, DH, Sabesin, SM & White, HM (1993) Fatty liver: biochemical and clinical aspects. In Diseases of the Liver, 7th ed., pp. 825871 [Schiff, L and Schiff, ER, editors]. Philadelphia, PA: JB Lippincott Company.
Barnett, CR, Flatt, PR & Ioannides, C (1988) Role of ketone bodies in the diabetes-induced changes in hepatic mixed-function oxidase activities. Biochimica et Biophysica Acta 967, 250254.
Black, M (1984) Acetaminophen hepatotoxicity. Annual Review of Medicine 35, 577593.
Burt, AD, MacSween, RNM, Peters, TJ & Simpson, KJ (1991) Non-alcoholic fatty liver: causes and complications. In Oxford Textbook of Clinical Hepatology, pp. 865871 [McIntyre, N, Benhamou, JP, Bircher, J, Rizetto, M and Rodes, J, editors]. Oxford: Oxford University Press.
Cousins, MJ, Plummer, JL & Hall, PM (1989) Risk factors for halothane hepatitis. Australian New Zealand Journal of Surgery 59, 514.
Day, CP & Yeaman, SJ (1994) The biochemistry of alcohol-induced fatty liver. Biochimica et Biophysica Acta 1215, 3348.
Eriksson, S, Eriksson, KF & Bondesson, L (1986) Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Medica Scandinavica 220, 8388.
Fiatarone, JR, Coverdale, SA, Batey, RG & Farrell, GC (1991) Non-alcoholic steatohepatitis: impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis. Journal of Gastroenterology and Hepatology 6, 585590.
Frayn, K & Kingman, S (1995) Dietary sugars and lipid metabolism in humans. American Journal of Clinical Nutrition 62, Suppl., 250S263S.
Girre, C, Lucas, D, Hispard, E, Menez, C, Dally, S & Menez, JF (1994) Assessment of cytochrome P450 2E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. iochemical Pharmacology 47, 15031508.
Horsmans, Y, De Konninck, X, Geubel, A & Pauwels, S (1995 a) Microsomal function in hepatitis B surface antigen healthy carriers: assessment of cytochrome P-450 1A2 activity by the 14C-caffeine breath test. Pharmacology Toxicology 77, 247249.
Horsmans, Y, Geubel, AP & Pauwels, S (1995 b) Reliability of aminopyrine breath test using a single breath collection. Digestive Diseases and Sciences 40, 1581.
Keeffe, EB, Adesman, PW, Stenzel, P & Palmer, RM (1987) Steatosis and cirrhosis in an obese diabetic. Resolution of fatty liver by fasting. Digestive Diseases and Sciences 32, 441445.
Kharasch, E Hankins D, Mautz, D & Thummel, KE (1996) Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis. Lancet 347, 13671371.
Krishnaswamy, K, Kalamegham, R & Naidu, NA (1984) Dietary influences on the kinetics of antipyrine and aminopyrine in human subjects. British Journal of Clinical Pharmacology 17, 139146.
Kuwahara, M & Hachimura, K (1980) Image enhancement and left ventricular contour extraction techniques applied to radioisotope angiocardiograms. Automedica 3, 107119.
Leclercq, I, Desager, JP & Horsmans, Y (1998 a) Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single-dose watercress ingestion. Clinical Pharmacology and Therapeutics 64, 144149.
Leclercq, I, Horsmans, Y & Desager, JP (1998 b) Estimation of chlorzoxazone hydrolase activity in liver microsomes and of the plasma pharmacokinetics of chlorzoxazone by the same high-performance liquid-chromatographic method. Journal of Chromatography 4, 291296.
Lee, RG (1989) Nonalcoholic steatohepatitis: a study of 49 patients. Human Pathology 20, 594598.
Mortelmans, L, Nuyts, Y, Van Pamel, G, Van Den Magdenbergh, V, De Roo, M & Suetens, P (1986) A new thresholding method for volume determination by SPECT. European Journal of Nuclear Medicine 12, 284290.
Osawa, H & Mori, Y (1996) Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes. Journal of Clinical Ultrasound 24, 2529.
O'Shea, D, Davis, SN, Kim, RB & Wilkinson, GR (1994) Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: A putative probe of CYP2E1 activity. Clinical Pharmacology and Therapeutics 56, 359367.
Ploeg, RJ, D'Alessandro, A, Knechtle, S, Stegall, MD, Pirsch, JD, Hoffmann, RM, Sasaki, T, Sollinger, HW, Belzer, FO & Kalayoglu, M (1993) Risk factors for primary dysfunction after liver transplantation — a multivariate analysis. Transplantation 55, 807813.
Raucy, JL, Lasker, JM, Lieber, C & Black, M (1989) Acetaminophen activation by human cytochromes P450IIE1 and P450IA2. Archives of Biochemistry and Biophysics 271, 270283.
Sheiner, LB (1983) ELSFIT (Version 3.0) A program for the extended least squares fit to individual pharmacokinetic data. San Francisco, CA: University of California.
Song, BJ, Veech, RL & Saenger, P (1990) Cytochrome P450IIE1 is elevated in lymphocytes from poorly controlled insulin-dependent diabetics. Journal of Clinical Endocrinology and Metabolism 71, 10361040.
Tapner, M, Liddle, C, Goodwin, B, George, J & Farrell, GC (1996) Interferon gamma down-regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes. Hepatology 24, 367373.
Weltman, MD, Farrell, GC, Hall, P, Ingelman-Sundberg, M & Liddle, C (1998) Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 27, 128133.
Yun, YP, Casazza, JP, Sohn, DH, Veech, RL & Song, BJ (1991) Pretranslational activation of cytochrome P450IIE1 during ketosis induced by a high fat die. Molecular Pharmacology 41, 474479.

Keywords

Dietary restriction of energy and sugar results in a reduction in human cytochrome P450 2E1 activity

  • Isabelle Leclercq (a1), Yves Horsmans (a1), Jean-Pierre Desager (a1), Stanislas Pauwels (a1) and André P. Geubel (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed